CFO sold ~$1.57M of Bristol Myers Squibb
Scheduled in advanceLoading…
Reporting person on SEC Form 4
David V Elkins
David V Elkins is Director at Bristol Myers Squibb. OQRO lists 17 transactions filed with the SEC under this name, the latest on Apr 2, 2026, each linked to the official Form 4.
Director
Disclosures on record
17
Companies involved
2
Disclosure history
CFO sold ~$278K of Bristol Myers Squibb
Scheduled in advanceCompensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.
Not classified as an open-market trade.
Not classified as an open-market trade.
Not classified as an open-market trade.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.